Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process. Jillian Kitchener has more.

general info

  • Uploaded    07/13/2020
  • Business & Finance
  • La cortina de azúcar de López-Gatell por su fracaso | Dinero en Imag...
  • Euro zone business activity resumes growth in July
  • Teladoc buys Livongo in $18.5 billion deal
  • Investing beyond stay-at-home stocks
  • S.Africa's diamond polishers look to lockdown lovers
  • Commerzbank sees 2020 loss from Wirecard, virus
  • Disney profit surprise lists Wall Street
  • The Japanese store with workers allowed until 80
  • Los peros de la recuperación económica en México | Dinero en Imagen